Prevalence, Treatment Patterns, and Outcomes of Individuals with EGFR Positive Metastatic Non-Small Cell Lung Cancer in a Canadian Real-World Setting: A Comparison of Exon 19 Deletion, L858R, and Exon 20 Insertion EGFR Mutation Carriers.

Autor: O'Sullivan DE; Department of Oncology, University of Calgary, Calgary, AB T2N 4N2, Canada.; Oncology Outcomes Initiative, University of Calgary, Calgary, AB T2N 4N2, Canada., Jarada TN; Department of Oncology, University of Calgary, Calgary, AB T2N 4N2, Canada.; Oncology Outcomes Initiative, University of Calgary, Calgary, AB T2N 4N2, Canada., Yusuf A; Department of Oncology, University of Calgary, Calgary, AB T2N 4N2, Canada.; Oncology Outcomes Initiative, University of Calgary, Calgary, AB T2N 4N2, Canada., Hu LXY; Oncology Outcomes Initiative, University of Calgary, Calgary, AB T2N 4N2, Canada., Gogna P; Oncology Outcomes Initiative, University of Calgary, Calgary, AB T2N 4N2, Canada.; Public Health Sciences, Queen's University, Kingston, Toronto, ON K7L 3N6, Canada., Brenner DR; Department of Oncology, University of Calgary, Calgary, AB T2N 4N2, Canada.; Oncology Outcomes Initiative, University of Calgary, Calgary, AB T2N 4N2, Canada., Abbie E; Janssen Inc., Toronto, ON M3C 1L9, Canada., Rose JB; Janssen Inc., Toronto, ON M3C 1L9, Canada., Eaton K; Janssen Inc., Toronto, ON M3C 1L9, Canada., Elia-Pacitti J; Janssen Inc., Toronto, ON M3C 1L9, Canada., Ewara EM; Janssen Inc., Toronto, ON M3C 1L9, Canada., Pabani A; Department of Oncology, University of Calgary, Calgary, AB T2N 4N2, Canada., Cheung WY; Department of Oncology, University of Calgary, Calgary, AB T2N 4N2, Canada.; Oncology Outcomes Initiative, University of Calgary, Calgary, AB T2N 4N2, Canada., Boyne DJ; Department of Oncology, University of Calgary, Calgary, AB T2N 4N2, Canada.; Oncology Outcomes Initiative, University of Calgary, Calgary, AB T2N 4N2, Canada.

Publikováno v: Current oncology (Toronto, Ont.) [Curr Oncol] 2022 Sep 30; Vol. 29 (10), pp. 7198-7208. Date of Electronic Publication: 2022 Sep 30.